Overall, our data from a large case series of male breast carcinomas in the Italian population confirm that the emerging three-tiered categorization of HER2 (HER2-0, HER2-low, and HER2-positive) can also be considered in MBC. Here, ERBB2 is linked to breast carcinoma.